SCHEMBL7029622

SCHEMBL7029622

C[Si](C)(CCCCC#N)c1ccccn1

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.41
ATM Q13315 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
LTB4R Q15722 1/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
GAA P10253 1/20 0.33
NPC1 O15118 2/20 0.32
RAB9A P51151 2/20 0.32
MAPT P10636 1/20 0.32
KDM4E B2RXH2 1/20 0.32
KCNN4 O15554 1/20 0.32
KCNA5 P22460 1/20 0.32
TSHR P16473 1/20 0.30
CTSL P07711 1/20 0.30
CTSK P43235 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7031166 0.95 ALDH1A1 (0.42) ALDH1A1ATML3MBTL1LTB4RMEN1
SCHEMBL7031647 0.80 CYP3A4 (0.33) ALDH1A1KDM4E
SCHEMBL7027980 0.80 TDP1 (0.34) ALDH1A1ATMMEN1KMT2ASMN1; SMN2
SCHEMBL7033054 0.80 LMNA (0.41) SMN1; SMN2NPC1RAB9AKDM4E
SCHEMBL7026422 0.78 KDM4E (0.43) SMN1; SMN2NPC1RAB9AKDM4E
SCHEMBL7028844 0.78 KDM4E (0.43) SMN1; SMN2NPC1RAB9AKDM4E
SCHEMBL7157608 0.78 KDM4E (0.43) SMN1; SMN2NPC1RAB9AKDM4E
SCHEMBL7034408 0.78 KDM4E (0.43) SMN1; SMN2NPC1RAB9AKDM4E
SCHEMBL7032571 0.78 CYP1A2 (0.41) SMN1; SMN2NPC1RAB9AKDM4EKCNA5
SCHEMBL7029461 0.77 ALDH1A1 (0.40) ALDH1A1MEN1KMT2AMAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030139600-A1 2-pyridylsilane, processes for producing and using the same SUMITOMO CHEMICAL CO., LTD. 2003-07-24 US disclosed
US-6548673-B1 Alkylation using transition metal complex catalyst; purified by acid/base extraction SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2003-04-15 US disclosed
US-6531602-B2 Desilylation of a 2-pyridylsilane to form an alcohol SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2003-03-11 US disclosed
US-20020165397-A1 2-Pyridylsilane, processes for producing and using the same SUMITOMO CHEMICAL CO., LTD. 2002-11-07 US disclosed
EP-1035125-A2 2-Pyridylsilane, processes for producing and using the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2000-09-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020165397-A1 2-Pyridylsilane, processes for producing and using the same H1-0, RIOK2, H1-4 ALDH1A1 497/4885ATM 1868/4885L3MBTL1 2878/4885
US-20030139600-A1 2-pyridylsilane, processes for producing and using the same H1-0, H1-4, H1-2 ALDH1A1 479/4885ATM 1769/4885L3MBTL1 2790/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.